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We	 report	 characterization	 of	 a	 methicillin-susceptible,	
vancomycin-resistant bloodstream isolate of Staphylococ-
cus aureus	recovered	from	a	patient	in	Brazil.	Emergence	of	
vancomycin resistance in methicillin-susceptible S. aureus 
would indicate that this resistance trait might be poised to 
disseminate more rapidly among S. aureus and represents 
a	major	public	health	threat.
Acquisition of high-level vancomycin resistance by Staphylococcus aureus represents a major pub-
lic health risk because this antimicrobial drug continues 
to be the first-line and most inexpensive therapy to treat 
methicillin-resistant S. aureus (MRSA) despite concerns 
about its clinical efficacy. Recently, we described vanco-
mycin-resistant MRSA (VR-MRSA) recovered from the 
bloodstream of a patient in Brazil (1). VR-MRSA belongs 
to sequence type (ST) 8 and is phylogenetically related to 
the community-associated (CA) MRSA USA300 genetic 
lineage that has rapidly disseminated in the United States 
and the northern region of South America (USA300-Latin 
American variant [USA300-LV]) (1,2). The vanA gene 
cluster in VR-MRSA was carried by a transferable staphy-
lococcal plasmid (pBRZ01). We characterized a clinical 
isolate of vancomycin-resistant, methicillin-susceptible S. 
aureus (VR-MSSA) and document the in vivo transfer of 
the vanA gene cluster to 2 unrelated S. aureus strains caus-
ing bacteremia within the same patient.
The Study
On August 28, 2012, a blood culture from a patient in Bra-
zil was reported positive for 2 isolates of MSSA while the 
patient was receiving daptomycin therapy (online Techni-
cal Appendix, http://wwwnc.cdc.gov/EID/article/21/10/14-
1914-Techapp1.pdf). One MSSA isolate was susceptible 
to all antimicrobial drugs tested (VS-MSSA). The second 
isolate (VR-MSSA) had a vancomycin MIC of 256 µg/
mL and was also resistant to gentamicin (Table 1). Both 
isolates were susceptible to daptomycin (MIC 0.5 μg/mL). 
Thirteen days earlier, 2 MRSA isolates, 1 of which was 
resistant to vancomycin (VR-MRSA), were recovered from 
the blood of the same patient (online Technical Appendix) 
(1). The daptomycin MICs for both MRSA strains were 
also 0.5 μg/mL.
Bacterial strains used in this study (Table 1) were grown 
in brain–heart infusion broth and agar. Plasmid pBRZ01 
was transferred by using filter mating (3) and VR-MSSA 
and VR-MRSA as donors and VS-MSSA, VS-MRSA, and 
RN4220RF as recipients (Table 1). Transconjugants were 
selected on brain heart infusion medium containing vanco-
mycin (32 µg/mL) and fusidic acid (25 µg/mL). Colonies 
from each mating experiment were subjected to digestion 
with SmaI and pulsed-field gel electrophoresis to investi-
gate genetic relatedness (1). Plasmids carrying the vanA 
gene cluster were detected by using S1 nuclease digestion 
followed by hybridization with a vanA probe (4).
Whole-genome sequencing of VR-MSSA, VS-MS-
SA, and 2 representatives of the Chilean/Cordobes clone 
(M1, M91) was performed by using MiSeq PacBio RS II 
(Illumina, San Diego, CA, USA) to close the VR-MSSA 
genome (5) (online Technical Appendix). Phylogenetic 
analysis was performed by using the maximum-likelihood 
framework within RAxML v7.4.2 (6). For cell wall analy-
sis, extraction and separation of peptidoglycan precursors 
was performed as described (7).
The PFGE patterns of both isolates (VR-MSSA and 
VS-MSSA) were indistinguishable, and in vitro growth 
rates were similar (Figure 1, panel A). S1 nuclease analy-
ses indicated that VR-MSSA harbored a plasmid of ≈55 
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kb, which yielded a positive result when hybridized with 
a vanA probe (Figure 1, panels B, C) and was similar in 
size to the previously described vanA-containing plasmid 
pBRZ01 identified in the same patient (1). pBRZ01 of 
VR-MSSA was readily transferred to S. aureus RN4220-
RF (efficiency = 3 × 10–5/donor). In vitro conjugative 
transfer of pBRZ01 between MRSA and MSSA strains 
recovered from the patient’s bloodstream was also readily 
achieved with efficiencies ranging from 4.3 × 10–7/donor 
to 2.5 × 10–6/donor. Acquisition of the pBRZ01 by corre-
sponding strains resulted in resistance to vancomycin and 
gentamicin (Table 1).
Genome sequencing (online Technical Appendix) 
showed that VR-MSSA and VS-MSSA belong to clonal 
complex (CC) 5 (sequence type ST5) and harbor staphylo-
coccal protein A (Spa) type t002. VS-MSSA and VR-MS-
SA have the characteristic CC5 genetic traits described by 
Kos et al. (8). The genome of VR-MSSA has a 2,906,602-
bp chromosome and 3 extrachromosomal elements, in-
cluding a plasmid of 55,713 bp identical to the previously 
described vanA-carrying pBRZ01 (1), which also harbors 
aac(6′)-aph(2′′), which confers gentamicin resistance.
Comparison of the core genomes of VR-MSSA and 
VS-MSSA showed only 20 single-nucleotide polymor-
phism differences, which suggested a close genetic rela-
tionship and probably representing the same organism that 
acquired pBRZ01. Phylogenetic analysis (Figure 2) con-
firmed that VR-MSSA is not a derivative of VR-MRSA (1) 
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Table 1. Staphylococcus aureus strains	used	in	analysis	of	methicillin	and	vancomycin	resistance,	Brazil* 
Strain Strain characteristics 
MIC,	g/mL 
Reference Vancomycin Gentamicin 
VS-MRSA Isolated	from	the	bloodstream	of	a	patient	in	Brazil 0.5 0.5 (1) 
VR-MRSA Isolated from the blood of the same patient above and 
carrying vanA-containing	pBRZ01 
>256 32 (1) 
VS-MSSA Isolated	from	the	blood	of	the	same	patient	13	d	after	
isolation of	VR-MRSA 
1 0.75 This study 
VR-MSSA Isolated	from	the	same	blood	culture	as	VS-MSSA 256 48 This study 
RN4220-RF Laboratory	strain	of	S.aureus used as recipient for mating 
experiments; fusidic acid and rifampin-resistant 
1 1 (1) 
Transconjugant	1† Transconjugant	obtained	from	a	mating	experiment	using	
VR-MSSA	as	donor	and	VS-MRSA	as	recipient 
>256 48 This study 
Transconjugant	2† Transconjugant	obtained	from	a	mating	experiment	using	
VR-MRSA	as	donor	and	VS-MSSA	as	recipient 
>256 64 This study 
Transconjugant	3† Transconjugant	obtained	from	a	mating	experiment	using	
VR-MSSA	as	donor	and	RN4220-RF	as	recipient 
>256 64 This study 
*VS-MRSA,	vancomycin-susceptible, methicillin-resistant S. aureus;	VS-MSSA,	vancomycin-susceptible, methicillin-susceptible S. aureus;	VR-MSSA,	
vancomycin-resistant, methicillin-susceptible S. aureus. 
†A fusidic acid–resistant derivative was generated for mating experiments. All mating experiments were performed on brain heart infusion agar in the 
presence of vancomycin (32	µg/mL)	and	fusidic	acid (25	µg/mL)	to	select	for	transconjugants. 
 
Figure 1.	Molecular	typing	of	Staphylococcus aureus	strains,	Brazil.	A)	SmaI	digestion	of	total	DNA,	followed	by	pulsed-field	gel	
electrophoresis.	Lane	M,	lambda	ladder	(molecular	masses	are	indicated	in	kilobases	on	the	left);	lane	1,	vancomycin-susceptible,	
methicillin-resistant S. aureus	(VS-MRSA)	isolated	from	the	blood	of	a	Brazilian	patient	(1);	lane	2,	vancomycin-resistant	MRSA	
(VR-MRSA)	isolated	from	the	same	patient	and	blood	culture	(1);	lane	3,	transconjugant	1	obtained	from	a	mating	experiment	using	
vancomycin-resistant	MSSA	(VR-MSSA)	as	donor	and	VS-MRSA	as	recipient;	lane	4,	vancomycin-susceptible	MSSA	(VS-MSSA)	
isolated	from	the	blood	of	the	same	patient	13	days	after	isolation	of	VR-MRSA;	lane	5,	VR-MSSA	isolated	at	the	same	time	as	VS-
MSSA;	lane	6,	transconjugant	2	obtained	from	a	mating	experiment	using	VR-MRSA	as	donor	and	VS-MSSA	as	recipient;	lane	7,	
S. aureus	RN4220	RF,	lane	8,	transconjugant	3	obtained	using	VR-MSSA	as	donor	and	RN4220	RF	as	recipient.	B)	S1	digestion	of	
total	DNA	using	the	same	strains	shown	in	panel	A.	C)	Hybridization	with	vanA probe using the same strains shown in panel A. Arrow 
indicates a positive signal for the vanA gene.
DISPATCHES
(isolated days before from the same patient) and empha-
sized the relationship of this strain to other vancomycin-
resistant S. aureus and MRSA isolates with intermediate 
susceptibility to vancomycin (VISA).
We analyzed the pool of cytoplasmic peptidoglycan 
precursors of VR-MSSA grown in the absence or pres-
ence of 50 μg/mL of vancomycin for induction of the vanA 
cluster (Table 2). Tandem mass spectrometry analysis 
identified 3 nucleotide precursors ending in d-alanyl-d-
alanine (UDP-MurNAc-pentapeptide), d-alanyl-d-lactate 
(UDP-MurNAc-pentadepsipeptide), and d-Ala (UDP-
MurNAc-tetrapeptide). Upon induction with vancomycin, 
UDP-MurNAc-pentapeptide was not detected, and UDP-
MurNAc-pentadepsipeptide accounted for most of the 
precursors (Table 2). These results indicate that the van-en-
coded enzymes required for incorporation of d-Lac into the 
precursors were fully functional in VR-MSSA. Our results 
also show that the vanA cluster was inducible by vancomy-
cin in the S. aureus host because only a small proportion 
of the precursors (4%) ended in d-Lac in the absence of 
the drug.
Analyses of cell wall muropeptides from VR-MSSA 
showed 2 modifications of the l-Ala1-γ-d-Glu2-l-Lys3-d-
Ala4-d-Ala5 stem peptide that are highly conserved in S. 
aureus strains, namely the amidation of the α-carboxyl of 
d-Glu2 to form d-iGln2 and the addition of a pentaglycine 
side chain on the ε-amino group of l-Lys3 by the Fem ami-
no-acyltransferases (9). Induction of the vanA gene cluster 
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Figure 2. Phylogenetic analyses of Staphylococcus aureus	strains,	Brazil.	Whole-genome	phylogenetic	tree	(dataset	=	325,732	single-
nucleotide	polymorphisms,	gamma-based	log	likelihood	− 1909607.06950)	of	the	S. aureus species showing position of vancomycin-
resistant, methicillin-susceptible S. aureus	(VR-MSSA)	and	vancomycin-susceptible	MSSA	(VS-MSSA)	isolates	sequenced	for	this	
study.	Vancomycin-resistant	S.	aureus	(VRSA)	strains	are	shown	in	red.	Numbers	on	branches	are	bootstrap	values	based	on	1,000	
resampling	iterations.	All	branches	without	numbers	had	bootstrap	values	of	100%.	Branch	lengths	are	proportional	to	number	of	
nucleotide	substitutions	per	site	(scale	bars).	Inset	labeled	CC5	is	expanded	to	emphasize	the	polyphyly	of	VRSA	strains.	*Genomes	
sequenced	for	this	study.	M1	and	M91	are	members	of	the	Chilean/Cordobes	clone	that	is	widespread	in	Latin	America	(online	Technical	
Appendix,	http://wwwnc.cdc.gov/EID/article/21/10/14-1914-Techapp1.pdf).	CC,	clonal	complex.
Methicillin-Susceptible,	Vancomycin-Resistant	S. aureus
led to 2 major modifications. First, stem peptides ended in 
d-Ala4, indicating that the peptidyl- d-Ala4- d-Ala5 target of 
vancomycin, and d-Ala4-d-Lac5 termini, were fully elimi-
nated. Second, the pentaglycine side chain was frequently 
missing (online Technical Appendix), indicating that re-
placement of d-Ala by d-Lac at the extremity of peptido-
glycan precursors might have impaired the ability of Fem 
transferases to add Gly on l-Lys3.
Conclusions
In this study, we demonstrated that the vanA-containing 
pBRZ01 plasmid previously described in MRSA was ac-
quired by an invasive MSSA isolate within the same pa-
tient. Our findings also suggest that a vanA-containing 
plasmid (pBRZ01) was horizontally acquired at least 
twice during a short period by distinct S. aureus lineages 
within the same host (MRSA belonging to ST8 and an ST5 
MSSA). VR-MSSA belongs to the ST5 lineage of CC5, a 
major hospital-associated lineage (10). The prevalent hos-
pital-associated lineages circulating in Brazil are ST5 (New 
York/Japan and Pediatric clones), ST239 (Brazilian clone) 
and ST1 (USA400 clone) (11), and recent epidemiologic 
data showed replacement of the endemic Brazilian (ST239) 
clone by ST5 strains (11–13). Moreover, VR-MSSA is re-
lated to ST5 vancomycin-resistant S. aureus strains recov-
ered in the United States (8) and to VISA isolates, including 
Mu50 and the hetero-VISA strain Mu3, initially recovered 
in Japan (14). It remains unclear why CC5 strains appear 
more likely to exhibit vancomycin resistance.
Our biochemical analysis indicates that the vanA gene 
cluster is fully functional in VR-MSSA, which leads to 
vancomycin-inducible production of d-Lac ending precur-
sors and elimination of d-Ala- d-Ala containing peptido-
glycan, as found in the enterococci (15). Our results also 
revealed a defect in side chain synthesis, although this did 
not prevent the synthesis of a functional and highly cross-
linked peptidoglycan in VR-MSSA.
In summary, we report the in vivo acquisition of high-
level vancomycin resistance in a bloodstream MSSA iso-
late. Of note, vanA-containing pBRZ01 was maintained 
even after the selective pressure of vancomycin had been 
removed, raising serious concerns about the possibility of 
further spread of resistance to this agent. However, no other 
MSSA strains containing this plasmid have been isolated 
so far in Brazil.
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Table 2. Relative abundance of peptidoglycan precursors in Staphylococcus aureus strains,	Brazil* 
Precursor 
Monoisotopic	mass  Abundance	(%)	in	corresponding	strains 
Observed Calculated  VS-MSSA VR-MSSA	(not	induced) VR-MSSA	(induced) 
UDP-MurNaAc-tetrapeptide 1,078.35 1,078.35  27 32 29 
UDP-MurNAc-pentapeptide 1,149.37 1,149.39  73 64 ND 
UDP-MurNAc-pentadepsipeptide 1,150.37 1,150.37  ND 4 71 
*Bacteria	were	grown	on	brain	heart	infusion	(BHI)	broth	(not	induced)	or	BHI	supplemented	with	vancomycin	(50	μg/mL).	VS-MSSA,	vancomycin-
susceptible, methicillin-susceptible S. aureus;	VR-MSSA,	vancomycin-resistant, methicillin-susceptible S. aureus; ND,	not	detected. 
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